
Health Law Alliance is publishing this alert to inform pharmacies and providers of a significant enforcement trend that could have serious implications for your business operations. ESI has drastically increased the number of audits it conducts of telehealth relationships, including providers that have contractual relationships with a provider named EZScripts. If you are doing business with EZScripts or other telehealth platforms, you will be subject to increased scrutiny from ESI and other PBMs.
Claim Phishing Audits on the Rise
Telehealth platforms often use pharmacies' National Provider Identifier (NPI) number to run "test" claims, often referred to as benefits eligibility checks.
PBMs and other entities involved in the claims adjudication process, such as McKesson's RelayHealth "switch," typically use "terms and conditions" and other contractual provisions to prohibit these transmissions.
ESI is now attempting to recoup on claims that are associated with these eligibility checks, irrespective that the claims are reversed and not paid. Specifically, ESI is demanding that pharmacies repay the entire amount at issue, meaning the entire dollar value arising from both paid and test claims.
This situation is deeply concerning. ESI is not only reclaiming all reimbursements made to these pharmacies, but also seeking to recover the monetary value of test claims for which pharmacies were never reimbursed, placing the financial stability of numerous pharmacies in jeopardy.
We Defend You Against ESI
If your pharmacy has done business with telehealth platforms such as Noble or EZScripts, and you have received an audit notice from ESI, we strongly urge you to contact us immediately. Our experienced PBM audit attorneys will provide you with a free consultation to discuss your options and provide the legal guidance necessary to protect your pharmacy from potentially devastating financial repercussions. Schedule a free consultation now.
MORE ARTICLES BY CATEGORY
PBM Enforcement Trends Independent Pharmacies Must Prepare for in 2026
Independent pharmacies are heading into 2026 under tighter PBM oversight, more aggressive audit practices, and evolving reimbursement models driven by regulatory pressure and DIR fee reform. To survive in this environment, pharmacies must strengthen compliance, documentation, and inventory controls while partnering with experienced PBM counsel to manage audits, protect reimbursements, and avoid network termination.
Read More >>PBM Audit Triggers: Understanding How Prescription Activity Is Evaluated
Pharmacy benefit managers (PBMs) increasingly use data analytics and algorithmic surveillance to identify “red flag” prescriptions and atypical dispensing patterns, which can trigger audits, recoupments, network terminations, and payment withholds for independent pharmacies. By understanding common PBM risk indicators and implementing strong compliance practices, internal audits, documentation, and timely legal support, pharmacies can reduce exposure and more effectively defend themselves during PBM reviews and appeals.
Read More >>Health Law Alliance Successfully Reverses OptumRx’s Network Termination for a Michigan Pharmacy
We are proud to announce that the Health Law Alliance has successfully reversed a network termination from OptumRx for a Michigan-based independent pharmacy.
Read More >>What to Expect in a Wound Care Audit - And Why You Shouldn’t Go It Alone
In 2025, wound care audits have become a top enforcement priority for federal and private payors, leaving providers unprepared and facing thousands in recoupments. Understanding how wound care audits progress is crucial to defending your practice from unjust penalties, and engaging counsel early is essential to protecting your practice. Learn how Health Law Alliance can help prepare a strategy-driven defense designed to minimize risk and preserve your practice’s reputation.
Read More >>







